What are Onivyde (Irinotecan Liposome) Chemotherapies? List from Cancer Survivors
The below is a list that has been posted by the bloggers in this cancer community. There are 7616 cancer fighters that are members here. This is what they said, not what the doctors or nurses will tell you.
Select Type
Choose which type you want to see information for. Just change your selection below.
Most Common
This is a tag cloud of the top words that people have experienced regarding the cancer type selected above.
Onivyde (Irinotecan Liposome) Chemotherapy Chemotherapies
What Onivyde (Irinotecan Liposome) Chemotherapy Cancer Survivors said about their Chemotherapies.
Gemcitibine plus Xeloda started March 2010 continuing through August 2010. The disease was in remission until August 2012, when metastases to the lungs was diagnosed, and the cancer progressed to Stage 4. Gemcitibine plus Xeloda followed until a chemo break in May 2013 was prescribed due to indolent nature of lung mets and hand/foot syndrome. With increasing size of lung mets, January 2014 began with chemo consisting of Abraxane plus Gemcitibine again. Metastases to peritoneum diagnosed in September 2015. Progression of metastases in May 2016 led to a determination that gemcitibine-based chemotherapy had ceased to be effective, and a new regimen of Onivyde plus 5-FU with leucovorin commenced. BRCA-1 mutation discovered and so the PARP inhibitor Olaparib was started in early 2017.
Fetching more entries....